Ibrutinib

936563-96-1

Ligands for Target Protein for PROTAC, BTK, Src, Tyrosine Kinases

PROTAC, Tyrosine Kinase/Adaptors, Angiogenesis

0.9995

Ibrutinib (PCI-32765) is an irreversible inhibitor of BTK (IC50: 0.5 nM) that selectively blocks B cell activation.

NC1=C2C(N(N=C2C3=CC=C(OC4=CC=CC=C4)C=C3)[C@H]5CN(C(C=C)=O)CCC5)=NC=N1

C25H24N6O2

440.5

Ice Packs

-20°C